XML 48 R37.htm IDEA: XBRL DOCUMENT v3.25.2
Note 4 - Business Combination - Purchase Considerations (Details) - USD ($)
$ in Thousands
Apr. 30, 2025
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2023
Goodwill   $ 5,175 $ 0 $ 0
Evoke Neuroscience, Inc. [Member]        
Cash $ 3,000      
Common stock 2,743      
Earn-Out Shares 478      
Total Purchase Consideration 6,221      
Working capital 139      
Security deposit 3      
Deferred revenue, non-current portion 56      
Fair Value of Identified Net Assets 1,046      
Goodwill 5,175      
Evoke Neuroscience, Inc. [Member] | Developed Technology Rights [Member]        
Identified intangible asset 700      
Evoke Neuroscience, Inc. [Member] | Trade Names [Member]        
Identified intangible asset 150      
Evoke Neuroscience, Inc. [Member] | Noncompete Agreements [Member]        
Identified intangible asset $ 110